Coagulation Proteins and Reagents

Product #

Description

Add to Cart
A0472 Acetyl-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2 [Disulfide bridge: 3-13] ≥95% (HPLC)
    • A8171 D-Ala-Leu-Lys-7-amido-4-methylcoumarin ≥95% (HPLC)
    • A2504 6-Aminocaproic acid ≥99% (titration), powder
    • A7824 6-Aminocaproic acid BioUltra, ≥99%
    • A8456 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride ≥97%
    • A6191 Antipain dihydrochloride from microbial source protease inhibitor
    • A9141 Antithrombin III from bovine plasma lyophilized powder, 200-400 units/mg protein (E1%/280 = 6.5)
    • A2221 Antithrombin III from human plasma lyophilized powder, ≥95% (SDS-PAGE)
    • A6397 Antithrombin III from rat plasma lyophilized powder, >200 units/mg protein (E1%/280 = 6.5)
    • A1153 Aprotinin from bovine lung lyophilized powder, 3-8 TIU/mg solid
    • B1260 N-Benzoyl-Phe-Val-Arg 4-methoxy-β-naphthylamide hydrochloride
    • B7632 N-Benzoyl-Phe-Val-Arg-p-nitroanilide hydrochloride protease substrate
    • B4758 N-Benzoyl-Val-Gly-Arg p-nitroanilide hydrochloride protease substrate
    • T3080 Beta-Thromboglobulin from human platelets ≥95% (SDS-PAGE)
    • B9385 Boc-Val-Pro-Arg-7-amido-4-methylcoumarin hydrochloride
    • E0518 C1 Esterase Inhibitor from human plasma aqueous solution, ≥95% (SDS-PAGE)
    • S5770 Citrate Concentrated Solution BioReagent, suitable for coagulation assays, 4 % (w/v)
    • C3821 Citrate-dextrose solution (ACD) sterile-filtered
    • C7165 Citrate-phosphate-dextrose solution aseptically filled
    • C4431 Citrate-phosphate-dextrose solution with adenine
    • D7910 3,4-Dichloroisocoumarin serine protease inhibitor
    • D0879 Diisopropylfluorophosphate
    • E0504 Ecarin from Echis carinatus venom prothrombin activator
    • E0881 Elastatinal microbial
    • 2854 Ethylenediaminetetraacetic acid disodium salt solution 2%, solution
    • F3380 Factor V Activating Enzyme from Russell's viper venom lyophilized powder, 20 units/mg protein
    • F0806 Factor IX human aqueous glycerol solution, ≥145 units/mg protein
    • F3301 Factor Xa chromogenic substrate solid
    • F0681 Factor V human aqueous glycerol solution, ≥25 units/mg protein
    • F0931 Factor Va human ≥1500 units/mg protein
    • F5386 Fibrin from human plasma insoluble powder
    • F8630 Fibrinogen from bovine plasma Type I-S, 65-85% protein (≥75% of protein is clottable)
    • F4753 Fibrinogen from bovine plasma 55-70% protein (≥ 90% of protein is clottable)
    • F7128 Fibrinogen from canine plasma
    • F8513 Fibrinogen from cat plasma
    • F3879 Fibrinogen from human plasma 50-70% protein (≥80% of protein is clottable)
    • F4883 Fibrinogen from human plasma 35-65% protein (≥90% of protein is clottable).
    • F4129 Fibrinogen from human plasma 55-75% protein, ≥60% of protein is clottable
    • F4385 Fibrinogen from murine plasma ~50% protein (>80% of protein clottable)
    • F6755 Fibrinogen from rat plasma 60-80% protein (≥60% of protein is clottable)
    • F3379 Fibrinopeptide B human ≥97% (HPLC)
    • F3254 Fibrinopeptide A human ≥96% (HPLC)
    • F3261 [Glu1]-Fibrinopeptide B human ≥90% (HPLC)
    • G2417 Gabexate mesylate analytical standard, for drug analysis
    • EG Globulins from chicken egg white
    • G8138 Globulins, baboon
    • G4640 Globulins Cohn fraction IV-4 from rabbit
    • G6265 Globulins Cohn fraction IV-4 porcine
    • G8148 Gly-Arg-p-nitroanilide dihydrochloride unokinase and plasmin substrate
    • G1895 Gly-Pro-Arg-Pro ≥97% (HPLC)
    • G5779 Gly-Pro-Arg-Pro amide ≥97% (HPLC)
    • H3393 Heparin sodium salt from porcine intestinal mucosa Grade I-A, ≥180 USP units/mg
    • H3149 Heparin sodium salt from porcine intestinal mucosa Grade I-A, ≥180 USP units/mg, powder, BioReagent, suitable for cell culture
    • H5515 Heparin sodium salt from porcine intestinal mucosa ≥150 IU/mg (dry basis)
    • H7016 Hirudin from leeches lyophilized powder, ≥1,500 ATU/mg protein (ATU = antithrombin units)
    • H7380 Hirudin from leeches lyophilized powder, 300-1,500 ATU/mg protein (ATU = antithrombin units)
    • H6894 [Tyr(SO3H)63]-Hirudin Fragment 54-65 ≥95% (HPLC)
    • H0393 Hirudin from leeches recombinant, expressed in Saccharomyces cerevisiae, ≥7,000 ATU/mg protein (ATU = antithrombin units)
    • K3627 Kallikrein from porcine pancreas ≥40 units/mg protein
    • K1632 Kininogen high molecular weight, Two Chain from human plasma lyophilized powder
    • K3628 Kininogen, low molecular weight from human plasma ≥95% (SDS-PAGE), lyophilized powder
    • L2023 Leupeptin trifluoroacetate salt ≥90% (HPLC), microbial
    • M3398 α2-Macroglobulin from human blood plasma Prestained
    • M6159 α2-Macroglobulin from human plasma BioUltra, ≥98% (SDS-PAGE)
    • M1882 Myoglobin from equine heart ≥90% (SDS-PAGE), essentially salt-free, lyophilized powder
    • M0630 Myoglobin from equine skeletal muscle 95-100%, essentially salt-free, lyophilized powder
    • M6036 Myoglobin from human heart ≥95% (SDS-PAGE), buffered aqueous glycerol solution
    • M7527 Myoglobin from sperm whale skeletal muscle recombinant, expressed in E. coli, 95-100%, buffered aqueous solution
    • P7626 Phenylmethanesulfonyl fluoride ≥98.5% (GC)
    • B4503 Plasma barium sulfate eluate from bovine plasma lyophilized powder
    • P1867 Plasmin from human plasma lyophilized powder, ≥2.0 units/mg protein
    • P9156 Plasminogen from bovine plasma lyophilized powder, ≥2.0 units/mg protein
    • P7397 Plasminogen from human plasma lyophilized powder, ≥2 units/mg protein
    • P2284 Plasminogen from rabbit plasma lyophilized powder, 4-10 units/mg protein
    • P2008 Polyanetholesulfonic acid sodium salt powder
    • P2200 Protein C from human plasma Activated, lyophilized powder, ≥90% (SDS-PAGE)
    • P7489 Protein Z from human plasma aqueous glycerol solution
    • R7752 Ristomycin monosulfate ≥90% ristocetin A basis (balance primarily Ristocetin B)
    • S9009 Sar-Pro-Arg p-nitroanilide dihydrochloride thrombin substrate
    • S3134 Streptokinase from β-hemolytic Streptococcus (Lancefield Group C) lyophilized powder, ≥3,500 units/mg solid
    • T4648 Thrombin from bovine plasma lyophilized powder, 40-300 NIH units/mg protein (biuret)
    • T7513 Thrombin from bovine plasma lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280 = 19.5)
    • T9000 Thrombin from bovine plasma buffered aqueous solution, ≥125 NIH units/mg protein (biuret)
    • T6884 Thrombin from human plasma lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280, 18.3)
    • T7009 Thrombin from human plasma lyophilized powder, ≥1,000 NIH units/mg protein (E1%/280, 18.3)
    • T1063 Thrombin from human plasma lyophilized powder, ≥2800 NIH units/mg protein (E1%/280, 18.3)
    • T8885 Thrombin from human plasma lyophilized powder, Suitable for routine use in the thrombin time test
    • T4393 Thrombin from human plasma lyophilized powder, 1500-3500 NIH units/mg protein (E1%/280, 18.3), cell culture tested
    • T9135 Thrombin from human plasma lyophilized powder
    • T3068 Thrombin generation chromogenic substrate ≥90% (TLC), solid
    • T2943 Tissue plasminogen activator chromogenic substrate ≥95% (HPLC), solid
    • T0273 N-p-Tosyl-Gly-Pro-Arg 7-amido-4-methylcoumarin hydrochloride protease substrate
    • T1637 N-(p-Tosyl)-Gly-Pro-Arg p-nitroanilide acetate salt thrombin substrate
    • T6140 N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide acetate salt plasmin substrate
    • T7254 Nα-Tosyl-L-lysine chloromethyl ketone hydrochloride ≥96% (TLC), powder
    • V3138 D-Val-Leu-Lys 7-amido-4-methylcoumarin ≥99% (HPLC), lyophilized powder
    • V3263 D-Val-Leu-Lys 4-methoxy-2-naphthylamide solid
    • V0882 D-Val-Leu-Lys 4-nitroanilide dihydrochloride plasmin substrate
    • C9396 Z-Gly-Gly-Arg 7-amido-4-methylcoumarin hydrochloride protease substrate
    • C5770 Z-Gly-Gly-Arg 4-methoxy-β-naphthylamide hydrochloride